SEC 13F Intelligence

Managers / Q2 2019 · view latest →

ABRAMS CAPITAL MANAGEMENT, L.P.

CIK 0001358706 · 222 BERKELEY STREET, 21ST FLOOR, BOSTON, MA, 02116 · 617-646-6100

Reported Value
$3.7B
Q2 2019
Positions
19
Filings on Record
30
2019–present window
Filed
Aug 9, 2019
original filing

Summary

Abrams Capital Management, L.P. reported $3.7B in U.S.-listed holdings across 19 positions for Q2 2019.

Its largest position, CELG, represents 17.0% of the portfolio.

Compared with Q1 2019, the fund opened 2 new positions and exited 2.

Portfolio Metrics

Turnover
+8.3%
vs prior filed quarter
Top-10 Concentration
+80.8%
share of reported value
Largest Position
+17.0%
Celgene
New / Exited
2 / 2
positions this quarter

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $2.4BQ4 ’18Q1 ’19: $3.6BQ2 ’19: $3.7BQ3 ’19: $3.6BQ4 ’19: $3.2BQ4 ’19Q1 ’20: $2.5BQ2 ’20: $3.1BQ3 ’20: $3.2BQ4 ’20: $3.5BQ4 ’20Q1 ’21: $4.4BQ2 ’21: $4.5BQ3 ’21: $4.6BQ4 ’21: $4.6BQ4 ’21Q1 ’22: $4.3BQ2 ’22: $3.7BQ3 ’22: $3.5BQ4 ’22: $2.8BQ4 ’22Q1 ’23: $3.2BQ2 ’23: $3.5BQ3 ’23: $3.0BQ4 ’23: $3.2BQ4 ’23Q1 ’24: $3.2BQ2 ’24: $5.1BQ3 ’24: $6.2BQ4 ’24: $6.2BQ4 ’24Q1 ’25: $5.6BQ2 ’25: $6.1BQ3 ’25: $6.2BQ4 ’25: $5.7BQ4 ’25Q1 ’26: $4.6Bfilingsflow.com

Portfolio Composition

By security type
Common Stock: 83.8%Other: 9.7%ADR: 4.5%MLP: 2.0%
  • Common Stock · 83.8% · $3.1B
  • Other · 9.7% · $357M
  • ADR · 4.5% · $167M
  • MLP · 2.0% · $73M

Quarter-over-Quarter Changes full breakdown →

vs Q1 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
TMDXTRANSMEDICS GROUP INCNEW+3.50M3.50M+$88M$88M
CCOCLEAR CHANNEL OUTDOOR HLDGSNEW+3.35M3.35M+$16M$16M
CLEAR CHANNEL OUTDOOR HLDGSSOLD OUT−3.35M0−$18M$0
BNEDUSDBARNES & NOBLE ED INCSOLD OUT−4.26M0−$18M$0
CWHCAMPING WORLD HLDGS INCADDED+1.16M5.11M+$9M$63M
ORLYO REILLY AUTOMOTIVE INC NEWTRIMMED−214.2K533.9K−$93M$197M
PCGPG&E CORPHELD+025.00M+$128M$573M
TEVATEVA PHARMACEUTICAL INDS LTDHELD+018.05M−$116M$167M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q2 2019

19 positions
Export to Excel
#IssuerClass% PortfolioValue ↓Shares
1CELGCELGENE CORPhistory →COM16.96%$624M6.75M
2PCGPG&E CORPhistory →COM15.56%$573M25.00M
3BENFRANKLIN RES INChistory →COM9.24%$340M9.77M
4LADLITHIA MTRS INChistory →CL A7.42%$273M2.30M
5WILLIS TOWERS WATSON PUB LTDSHS5.77%$213M1.11M
6UHALAMERCOhistory →COM5.77%$212M561.3K
7METAFACEBOOK INChistory →CL A5.37%$198M1.02M
8ORLYO REILLY AUTOMOTIVE INC NEWhistory →COM5.36%$197M533.9K
9KMIKINDER MORGAN INC DELhistory →COM4.84%$178M8.53M
10TEVATEVA PHARMACEUTICAL INDS LTDhistory →SPONSORED ADS4.52%$167M18.05M
11AWGASBURY AUTOMOTIVE GROUP INChistory →COM4.36%$160M1.90M
12GOOGLALPHABET INChistory →CAP STK CL A3.65%$134M124.1K
13PACIFIC DRILLING SA LUXEMBOUCOM2.54%$93M7.41M
14TMDXTRANSMEDICS GROUP INChistory →COM2.39%$88M3.50M
15SPHSUBURBAN PROPANE PARTNERS Lhistory →UNIT LTD PARTN1.97%$73M2.99M
16CWHCAMPING WORLD HLDGS INChistory →CL A1.72%$63M5.11M
17OCH ZIFF CPTL MANGEMNT GRP ICL A NEW1.39%$51M2.22M
18AKBAAKEBIA THERAPEUTICS INChistory →COM0.74%$27M5.66M
19CCOCLEAR CHANNEL OUTDOOR HLDGShistory →COM0.43%$16M3.35M

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$4.6B11May 14, 202613F-HRchanges · EDGAR ↗
Q4 2025$5.7B12Feb 13, 202613F-HRchanges · EDGAR ↗
Q3 2025$6.2B13Nov 7, 202513F-HRchanges · EDGAR ↗
Q2 2025$6.1B13Aug 8, 202513F-HRchanges · EDGAR ↗
Q1 2025$5.6B13May 9, 202513F-HRchanges · EDGAR ↗
Q4 2024$6.2B13Feb 7, 202513F-HRchanges · EDGAR ↗
Q3 2024$6.2B14Nov 8, 202413F-HRchanges · EDGAR ↗
Q2 2024$5.1B14Aug 9, 202413F-HRchanges · EDGAR ↗
Q1 2024$3.2B13May 14, 202413F-HRchanges · EDGAR ↗
Q4 2023$3.2B15Feb 9, 202413F-HRchanges · EDGAR ↗
Q3 2023$3.0B15Nov 13, 202313F-HRchanges · EDGAR ↗
Q2 2023$3.5B17Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$3.2B16May 12, 202313F-HRchanges · EDGAR ↗
Q4 2022$2.8B16Feb 10, 202313F-HRchanges · EDGAR ↗
Q3 2022$3.5B18Nov 10, 202213F-HRchanges · EDGAR ↗
Q2 2022$3.7B18Aug 12, 202213F-HRchanges · EDGAR ↗
Q1 2022$4.3B18May 13, 202213F-HRchanges · EDGAR ↗
Q4 2021$4.6B18Feb 11, 202213F-HRchanges · EDGAR ↗
Q3 2021$4.6B18Nov 12, 202113F-HRchanges · EDGAR ↗
Q2 2021$4.5B16Aug 13, 202113F-HRchanges · EDGAR ↗
Q1 2021$4.4B16May 14, 202113F-HRchanges · EDGAR ↗
Q4 2020$3.5B17Feb 12, 202113F-HRchanges · EDGAR ↗
Q3 2020$3.2B19Nov 13, 202013F-HRchanges · EDGAR ↗
Q2 2020$3.1B20Aug 13, 202013F-HRchanges · EDGAR ↗
Q1 2020$2.5B22May 14, 202013F-HRchanges · EDGAR ↗
Q4 2019$3.2B21Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$3.6B20Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$3.7B19Aug 9, 201913F-HRchanges · EDGAR ↗
Q1 2019$3.6B19May 10, 201913F-HRchanges · EDGAR ↗
Q4 2018$2.4B19Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.